Product information and disease descriptionPlace of product in therapyDisease descriptionBurden of Open-angle glaucoma or ocular hypertension
Economic impact of diagnostic testing
6 evidence topics · 6 sources
Guideline statement: ancillary testing as a component of direct costs
Medicare Part B payments: optical coherence tomography of the optic nerve (CPT 92133), 2024
| Field | Office and other non-facility settings | Facility settings |
|---|---|---|
| Service description | “Imaging of optic nerve” | “Imaging of optic nerve” |
| Place of service code | “O” | “F” |
| Total beneficiaries | “2353950” | “59478” |
| Total services | “2704197.1” | “67036” |
| Average submitted charge (USD) | “111.02944985” | “107.26792037” |
| Average Medicare allowed amount (USD) | “34.480219382” | “21.326738021” |
| Average Medicare payment amount (USD) | “24.047622387” | “14.822967212” |
Medicare Part B payments: extended visual field examination (CPT 92083), 2024
| Field | Office and other non-facility settings | Facility settings |
|---|---|---|
| Service description | “Exam of visual field with extended testing” | “Exam of visual field with extended testing” |
| Place of service code | “O” | “F” |
| Total beneficiaries | “2256481” | “57345” |
| Total services | “2654750” | “67503” |
| Average submitted charge (USD) | “150.1505657” | “121.66678933” |
| Average Medicare allowed amount (USD) | “62.079533207” | “26.88252611” |
| Average Medicare payment amount (USD) | “43.643536035” | “18.909151741” |